We strive to add significant value to every engagement, leveraging the strengths and capabilities of the entire organization to offer a holistic methodology to problem solving.
Babak is a 30+ year veteran of the healthcare industry, serving in executive roles at leading corporations, such as Johnson & Johnson. He currently leads Strategic Intelligence, Inc., a comprehensive strategy consulting firm focused on the commercial development of new and emerging technologies in the medical device industry. He is a frequent advisor to venture capital, private equity, and strategic venture funds. Currently, Babak also serves as a consulting member of the Emerging Technologies Group of the Corporate Office of Science and Technology at Johnson & Johnson.
Babak started his career in the medical laser industry, and then joined J&J in corporate development roles. While at J&J, he served as the Director of Surgical Oncology for Ethicon and Ethicon Endo-surgery, and Chair of Medical Optics for the Corporate Office of Science and Technology. In these roles, he was responsible for strategic planning for new franchises within the Corporation, assessment of new and emerging technologies (sourced globally) for their strategic fit, technical merit, and commercial viability, and leading or contributing to licensing and acquisition negotiations with emerging companies.
Outside of J&J, Babak has served in executive roles for emerging medical device and biotechnology companies, in a wide range of specialties ranging from oncology, general surgery, ophthalmology, and women’s health, to dermatology and plastic surgery. He has a proven track record of success in a diverse range of operating responsibilities such as research and development, global program management, new business development, marketing and sales, corporate planning, and strategic management of clinical and regulatory functions.
He holds several patents in the field of medical optics, and has published a number of original articles in refereed journals. Additionally he has served as a member of the Advisory Board for the Medical Technology Program of Lawrence Livermore National Laboratory, Plebys International, and Nanoverse. His academic training includes a Bachelor of Arts in Physics (with Special Honors), Bachelor of Science in Mathematics, and a Master’s and a doctoral degree in Electrical and Biomedical Engineering, all from the University of Texas at Austin.
Debbie is an experienced business analyst serving SI's strategic consulting practices by focusing on key issues that small start up companies face in their growth cycle, ranging from product development issues, to proper positioning of emerging technologies in the market place, to development of a strong defensive and offensive intellectual property portfolio. Debbie has significant expertise in technical, clinical and market risk analysis of medical device opportunities, specialty pharmaceuticals, life science products and new chemical entities, and she serves as a specialist in global market evaluation including competitive assessment of technologies and products for startup, high growth and established corporate environments. Debbie has served as Executive Director of Intellectual Property at Epicyte Pharmaceuticals, Inc., Director of Intellectual Property at Sequenom, a scientific advisor for Lyon & Lyon, LLP, and as a freelance biotechnology writer for Nature Biotechnology. With over 15 years of experience in strategic corporate and business development in the biotechnology industry, Debbie was recognized as an "outstanding woman in business" by San Diego Business Journal.
Debbie holds a doctoral degree in microbiology from University of California at Los Angeles, a BA in Biology from University of California at San Diego, and she completed her postdoctoral training in the Departments of Molecular Biology and Chemistry at The Scripps Research Institute.
Roger has over 30 years of experience in the pharmaceutical and medical device/diagnostics area focused on the building significant new businesses in the global healthcare market. He has had hands-on experience across the entire spectrum of business creation from conceptualization through business formation, commercialization and successful exits. He has successfully operated in organizations ranging from raw start-ups to senior executive levels of Fortune 50 companies. Roger started his career at J&J in pharmaceutical sales and marketing, and soon focused on the introduction of new products and procedures into the global medical community. While at J&J he launched the Monistat™ franchise in the US. Roger then moved on to more entrepreneurial opportunities in drug delivery systems (ALZA) and the global development of surgical laser systems (Coherent Medical).
The next stage of his career involved the formation and management of several successful start-ups including: Advanced Interventional Systems, Inc. which addressed challenging vascular restenosis issues; VISX, Inc. developed and introduced laser refractive surgery (LASIK). Both achieved IPOs and a combined market value of $1.6B. He was also President of IntelliWire, Inc., a novel nitinol guide wire for improved vascular access which was acquired by a Japanese medical device company.
He was then recruited back to J&J as Vice President of Johnson & Johnson Development Corporation, the J&J venture capital subsidiary. In 9 years Roger invested in and sat on the Boards of Directors of over 20 early stage companies, guiding 9 of them to successful exits during his tenure.
Roger holds 3 medical device patents. He served on the Board of Directors of the American Society lasers in Medicine and Surgery. He currently serves on the Board of Mangers of Ascension Ventures, a strategic venture capital fund with $550M under management. He has a Bachelors degree in Biology from San Jose State University and a Certificate in Pharmaceutical Marketing from the Tuck School of Business, Dartmouth College.
Nicole Boramanand brings twenty years of experience that integrate clinical practice, technology innovation, and business development across medical device, biotechnology, and wireless health sectors. Her professional experience includes her role as Vice President for Clinical Systems Innovation at the West Health Institute, creating a translational clinical network for early stage innovation.
Prior to this, she was at Medtronic Incorporated in Corporate Development where she helped execute domestic and international strategic investments, acquisitions, and divestitures. Nicole practiced clinically for ten years as a pediatric nurse practitioner with a focus on cardiac electrophysiology and adult congenital heart disease. She spent her early career in biotechnology at Hybritech (acquired by Eli Lilly, Co.), Amylin Pharmaceuticals, and The Scripps Research Institute. Nicole has been an invited speaker in cardiology, electrophysiology, pediatric primary care, healthcare innovation and mobile health, and has served on the Advisory Board for 360 Fresh, a clinical analytics company, and CareSpeak, a mobile medication adherence company.
Nicole has a BS in Biochemistry & Cell Biology from University of California, San Diego, MSN from the Yale School of Nursing, and MBA from the Yale School of Management.
Steve has worked in the field of biophotonics as a research manager and researcher for the last 20 years, first in the Medical Technology Program at Lawrence Livermore National Laboratory, then for the last 5 years as an Adjunct Professor at the University of California, Davis. At UCD he has been a member of the Departments of Radiology and Neurological Surgery. Steve currently serves as the Chief Scientific Officer and Associate Director of the NSF funded Center for Biophotonics Science and Technology headquartered at UCD.
For most of his career, Steve has been involved in both applied research and the development of instrumentation for physics, biology, and medicine. His technical interests include medical sensors, x-ray and optical spectroscopy, imaging and microscopy, computer simulations of photon interaction and transport in tissue, and the development and commercialization of medical devices.
He completed M.S. and Ph.D. degrees in Applied Science Engineering from UCD, holds 15 patents, has over 100 peer reviewed publications, received two R&D 100 Awards, a DoE Award for Excellence in Technology Transfer and, at a White House ceremony, received the Department of Energy Bright Light Award for work on the development of an optical glucose sensor. Steve has led or participated in projects funded by DoE, DoD, DARPA, NIST, NIH, NSF, LLNL, and UC. He was the founder and executive officer of a start-up company that performed technical consulting and produced products for radiation detection and protection for research and for the radiopharmaceutical industry. He is currently or has formerly been a member of numerous boards and review panels including the Executive Committee of the UCD Cancer Center Biotechnology Program, the Research Advisory Committee of the UCD McClelland Nuclear Radiation Center, the Scientific Advisory Board for the Australian Research Council’s Centre of Excellence for Coherent X-Ray Science, the NSF Biophotonics Advanced Imaging and Sensing for Human Health (BISH) proposal review panel, the Special NIBIB Director's Optical Imaging Program Progress Review Committee, and the DoE Committee on New Frontiers in Characterizing Biological Systems. He has taught graduate classes in biomedical imaging and is currently an instructor for the Super-Resolution Microscopy short course at the annual Conference on Lasers and Electro Optics, Optical Society of America.
Dwight Duston has pursued a diversified 35-year professional career as a research scientist, technology manager, university professor, inventor and entrepreneur. He has managerial and technical expertise in a wide range of technologies in multiple industries, including defense, aerospace, bio-medical lasers, medical imaging, displays and ophthalmics.
He started as a research scientist at the US Naval Research Laboratory in the area of plasma physics, radiation, laser fusion and nuclear weapons simulation, and has more than 25 technical publications in peer-reviewed scientific journals. Advancing to technology management mid-career, Dr. Duston is former director of the Technology Division for the U.S. Strategic Defense Initiative Organization (now, the US Missile Defense Agency), popularly known as the “Star Wars” program. At the Pentagon, he managed research and development programs in structural and electronic materials, optics, lasers, particle beams, high-speed processing, imaging sensors, power, and propulsion. His office launched over 15 space missions during his tenure, including Clementine, the first space probe to discover ice on the moon. While at SDIO, he also managed the Congressionally-mandated Free Electron Laser Medical Program, the Small Business Innovation Research program, and SDI’s Technology Transfer Office. He has served on advisory panels to several other agencies, including the National Institutes of Health (digital mammography), NASA, DARPA and the Departments of Energy and Commerce.
Dwight retired from government service in 1998 to pursue a career in in the private sector. He joined The Egg Factory, a high-tech start-up, as CTO, in 1999 and worked on several inventions in a number of industries, including ophthalmics, information displays, solar photo-voltaic energy, adaptive optics, and electro-optics. He helped spin off PixelOptics Inc., the first company to commercialize electronic spectacle lenses, and served as Senior VP for Research & Technology until 2009. At another Egg Factory spin-off, eVision LLC, he managed the development of tunable electronic lenses for camera optics and cell phones, an electro-optic ophthalmic refractometer, and sun steering electro-optics for solar concentrators. He is listed as an inventor on 35 U.S. patents, with dozens more overseas. He taught physics as a US Peace Corps Volunteer in Malaysia, and was Associate Professor of Management & Technology at the University of Maryland.
Presently, he consults for aerospace companies, the U.S. Department of Defense and assists start-up companies in the biomedical industry. He received his B.S., M.S., and Ph.D. in physics from the University of Michigan.
Tom has more than 30 years of experience in engineering, manufacturing, R&D, and product and process development. He has extensive experience and a strong reputation within the ophthalmic medical device industry.
As an engineer and manager, Tom contributed to the success of Mobil Chemical Company, A&E Plastics, Beckman Instruments, and American Hospital Products. As Director of Product Development, R&D and Operations for Allergan/Advanced Medical Optics, Tom identified new product opportunities, led global commercialization teams, and oversaw design and development of all intraocular lens and insertion systems.
Tom’s professional experience includes Chief Operating Officer at HOYA Surgical Optics in Singapore. His leadership responsibilities included Research and Development, Quality, Regulatory Affairs, Clinical Research, Manufacturing, Global Supply Chain, and Project Management. As Director of Product Development – R&D and Operations for Allergan/Advanced Medical Optics, Tom identified new product opportunities, led global commercialization teams, and oversaw design and development of all intraocular lens and delivery systems.
Tom is the Principal and Founder of PATH Product Development, a product development consultancy that specialized in ophthalmic device technology. PATH partners with clients to provide planning and execution of all aspects of product development from the proof-of-concept stage through commercialization. Services are provided to entrepreneurs, as well as small and large companies. Recent engagements have included technology and product landscaping, technology transfer and licensing, manufacturing process analysis and development, project management and M&A due diligence.
Tom holds a Bachelor of Science degree in mechanical engineering from Union College in New York, a Biomedical Engineering certificate from the University of California, and a Quality Engineering certificate from the American Society for Quality. He also holds four patents for his intraocular lens discoveries.
Ed DeHoog, Ph.D., has extensive experience in the optics and optical engineering industry. He has worked in optical design engineering since 2005. He has published several scientific papers in the field of optics and optical engineering and is active with the Optical Society of America (OSA) and SPIE. Ed brings a wealth of experience and expertise in the field of optical design and analysis, equipped and proficient with ZEMAX and FRED optical engineering software. He has consulted for a number of companies in IOL and vision optics design and optimization. Ed holds a BS in Laser Optical Engineering from Oregon Institute of Technology, an MS in Applied Physics with an emphasis in Optical Physics, from Oregon State University, and a doctorate in biomedical engineering with an emphasis in optical engineering from the University of Arizona.
Kevin E. Daly
Kevin Daly has 30+ years experience in the medical device industry, most recently as COO for a combination (drug/device) start-up, and in securing FDA approvals (510(k), IDE, PMA) and establishing FDA/ISO quality management systems for FDA class II and III medical devices. Mr. Daly has held executive management positions with other medical device start-ups including MicroTherapeutics, Inc. (neurovascular implants, acquired by ev3), InterVentional Technologies, Inc. (coronary atherectomy, acquired by Boston Scientific), AccuLase, Inc. (excimer laser, acquire by PhotoMedex), and Meadox Medicals, Inc. (vascular grafts, acquired by Boston Scientific). His professional experience also includes executive management positions in multi-national medical device companies including C.R. Bard, Inc., Medtronic, Inc., and MicroVention, Inc. (Division of Terumo Medical, Japan). He also serves as volunteer Chair of the San Diego Regulatory Affairs Network (SDRAN) Internship Committee. He holds a B.S. in Biology from Fairleigh Dickinson University, N.J.
Mr. Stroup has vast experience in automated manufacturing and processing systems for the medical device, bio-diagnostic and pharmaceutical fields. David is an expert in the conceptualization and design of complex automated process and manufacturing systems and has extensive knowledge and know how in product and process development with an emphasis on automated manufacturability. In recent years David has focused on product development and generated a portfolio of proprietary designs in the field of disposable medical and bio-diagnostic devices. Previously, David founded and served as the Chief Executive Officer for Prodosyst Automation. David grew and diversified customer list to include several Fortune 500 companies. An exemplary list of client companies include Johnson & Johnson, Abbott Laboratories, Guidant Corporation, Cardinal Health, Tyco Electronics, Welch Allyn, and C R Bard. David applies his expertise at the foundation level of development producing designs with a strong emphasis on manufacturability. David leads engineering project management, design, and manufacturing engagements for our clients.
David holds a BS in Mechanical Engineering from San Diego State University, and has invented, developed, and engineered multiple disposable medical and bio-diagnostic devices.
Kory has 15 years of transactional and executive management experience including operations, strategic planning, turnarounds and financial management for a variety of healthcare organizations including medical device, pharmaceutical, biotechnology and hospitals. Kory has extensive experience in conducting due diligence, market assessment, valuation analysis, and advising on transaction structure, including securing licensing agreements. He has also advised clients to successfully drive their capital formation and fund raising activities.
As the Managing Director of Attentus, a boutique advisory firm providing management, operational turnaround and corporate finance services, Kory advised clients in various healthcare industries including hospitals and clinics, provider groups, medical devices, pharmaceutical, biotechnology, and sector-focused private equity firms. He has functioned in various roles including Chief Financial Officer, Chief Operating Officer, and various Vice President and Director positions. He has a demonstrated track record of turning around for profit, and not-for-profit, healthcare organizations through the design and implementation of critical initiatives.
Kory was a healthcare associate with Waveland Capital Group, an investment banking firm focused on funding and developing companies, mergers and acquisition advisory. He managed the transaction life cycle including sourcing, screening, structuring and execution of equity, debt, merger and acquisition transactions. Prior to that, Kory was a healthcare consultant providing financial analysis, financial and operational due diligence, valuation analyses, transaction management, post-merger integration planning, and market assessment for hospitals, medical device, pharmaceutical, and healthcare-focused financial services companies.
Kory is a member of the Healthcare Financial Management Association (HFMA) and Society of Competitive Intelligence Professionals (SCIP). Additionally, he has published articles on innovative medical devices and has lectured at UC Irvine on securing private equity investment.
Kory holds an MBA from the University of California at Irvine, an MS in Biomedical Sciences from University of New Mexico School of Medicine, and a BS in Chemistry from the University of Utah.
Having a passion for new products, technologies and innovations that improve health, longevity and lifestyle, Renee Bryan has spent the past 20+ years in the global life sciences industry, working for large multinational organizations such as STERIS, Kimberly-Clark and Teleflex Medical and more recently for six California-based early-stage companies. Her career began with the global product management function, progressed to strategic planning for accelerated growth and culminated in M&A, licensing and co-development activities to achieve inorganic growth for companies entering new markets.
She has deep experience in evaluating new technologies, products, markets and geographies for revenue growth in the medical device, diagnostics and digital health markets including market analysis & sizing, formulation of market entry strategies, business case financial justification and designing truly differentiated competitive positioning.
Noted for exceptional product launches, Renee was recruited to five different organizations to drive new products to commercialization or to put a new company on the competitive map. For mature businesses, she has built imaginative pathways for profitable growth through product line extensions and service enhancements that grew market share and made products and services “stick” to a customer base.
She is known as an inspiring leader of cross-functional teams which demonstrate accountability and meet tight deadlines. As an entrepreneurial minded designer of product pipelines deeply rooted in customer and Key Opinion Leader (KOL) insights, Renee ensures organizations stay ahead of competitors, maximizing commercial success.
Ms. Bryan has undergraduate degrees in Marketing and Finance from the University of Richmond and an MBA from Case Western Reserve University.